liposomal amphotericin B (AmBisome®)

TERMINATED · PHASE4 · Fungal Infection

Study closed due to recruitment challenges.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.